Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Panbela Therapeutics Inc
(OP:
PBLA
)
0.3500
-0.0125 (-3.45%)
Streaming Delayed Price
Updated: 3:09 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,909
Open
0.3675
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.3625
Today's Range
0.3500 - 0.3999
52wk Range
0.3000 - 0.9500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
September 24, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
August 14, 2024
PBLA stock results show that Panbela Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-49.27%
-49.27%
1 Month
-5.35%
-5.35%
3 Month
-4.76%
-4.76%
6 Month
-35.14%
-35.14%
1 Year
-49.27%
-49.27%
More News
Read More
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
July 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
June 24, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
June 10, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.